Sound Biologics
Pre-clinicalBiological systems underlying disease are complex, and targeting a single receptor or pathway through monotherapy rarely delivers maximal benefit. Cancer immunotherapy studies have shown that combining two antibodies can yield improved outcomes compared to single-agent therapy.
Founded
2016
Focus
AntibodiesBiologics
About
Biological systems underlying disease are complex, and targeting a single receptor or pathway through monotherapy rarely delivers maximal benefit. Cancer immunotherapy studies have shown that combining two antibodies can yield improved outcomes compared to single-agent therapy.
Funding History
2Total raised: $30M
Series A$25MUndisclosedJun 15, 2020
Seed$5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile